It is more important to increase the intake of unsaturated fats than to decrease the intake of saturated fats: Evidence from clinical trials relating to ischemic heart disease

American Journal of Clinical Nutrition

Volumn 66, Issue 4 SUPPL., 1997, Pages

  Oliver, Michael F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Clinical trials; Compliance; Diet; Ischemic heart disease; N 3 fatty acids; Polyunsaturated fat; Saturated fat

Indexed keywords

CHOLESTEROL; SATURATED FATTY ACID;

CIGARETTE SMOKING; CONFERENCE PAPER; DIET RESTRICTION; FAT INTAKE; HUMAN; ISCHEMIC HEART DISEASE; LOW FAT DIET; MORTALITY; PATIENT COMPLIANCE; RISK ASSESSMENT;

EID: 0030822023     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.4.980S     Document Type: Conference Paper

References (43)

1. Keys A. Seven countries. A multivariate analysis of diet and coronary heart disease. Cambridge, MA: Harvard University Press, 1980.
2. National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. First report. Arch Intern Med 1988;148:36-9.
3. National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Second report. Circulation 1994;89:1329-445.
4. Pyörälä K, De Backer G, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994;15:1300-31.
5. Turpeinen O, Karvonen MJ, Pekkarinen M, et al. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol 1979;8:99-118.
6. Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking on the incidence of coronary heart disease. Lancet 1981;2:1303-10.
7. Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality: findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 1992;152:1490-500.
8. World Health Organisation European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease. Lancet 1986;1:869-72.
9. Frantz ID, Dawson EA, Ashman PL, et al. Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arteriosclerosis 1989;9:129-35.
10. Strandberg TE, Salomaa VV, Naukkarinen VA, et al. Long-term mortality after 5 year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA 1991;266:1225-9.
11. Oliver MF. Doubts about preventing coronary heart disease. Br Med J 1992;304:393-4.
12. Research Committee to the Medical Research Council. Low fat diet in myocardial infarction. A controlled trial. Lancet 1965;2:501-4.
13. Woodhill JM, Palmer AJ, Leelarthaepin C, et al. Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Adv Exp Med Biol 1978;109:317-30.
14. Dayton S, Pearce ML, Hashimoto S, et al. A controlled clinical trial of a diet high in unsaturated fat preventing complications in atherosclerosis. Circulation 1969;39/40(suppl II):63-98.
15. Research Committee to the Medical Research Council. Controlled trial of soya-bean oil in myocardial infarction. Lancet 1968;2:693-700.
16. Leren P. The Oslo-Heart Study; eleven year report. Circulation 1970;42:935-42.
17. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 1989;2:757-61.
18. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alphalinolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-9.
19. Singh RB, Rastogi SS, Verma R, et al. Randomised controlled trial of cardioprotective diet in patients with recent myocardial infarction: results of one year follow up. Br Med J 1992;304:1015-20.
20. Burr ML, Sweetnam PM, Fehily AM. Diet and reinfarction. Eur Heart J 1994;15:1152-3.
21. Dart AM, Riemersma RA, Oliver MF. Effects of Maxepa on serum lipids in hypercholesterolaemic subjects. Atherosclerosis 1989;80:119-24.
22. Kromhout D, Bosschieter EB, de Coulander CL. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9 (letter).
23. Shekelle RB, Missell L, Paul O, et al. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985;313:820 (letter).
24. Vollset SE, Heuch I, Bjelke E. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985;313:820-1 (letter).
25. Curb JD, Reed DM. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985;313:821 (letter).
26. Aschierio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995;332:977-82.
27. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ. A prospective study of fish oil levels and incidence of myocardial infarction in U. S. male physicians. J Am Coll Cardiol 1995;25:387-94.
28. Donadio JV, Bergstralh MS, Offord MS, et al. A controlled trial of fish oil in IgA nephropathy. N Engl J Med 1994;331:1194-9.
29. Shahar E, Folom AR, Melnick SL, et al. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N Engl J Med 1994;331:228-33.
30. Goodnight SH, Cairns JA, Fisher M, Fitzgerald GA. Assessment of the therapeutic use of n-3 fatty acids in vascular disease and thrombosis. Chest 1992;102:374S-84S.
31. Weber PC. Atherosclerosis risk factor modification by n-3 fatty acids. Atherosclerosis Rev 1990;21:91-102.
32. McLennan PL, Abeywardena MY, Charnock JS. Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats. Can J Physiol Pharmacol 1985;63:1411-7.
33. Ornish D, Brown SE, Schwerwitz LW, et al. Can lifestyle changes reverse coronary heart disease? Lancet 1990;336:129-33.
34. Watts GF, Lewis B, Brunt JNH, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992;339:563-9.
35. Vos JW. Retardation and arrest of progression or regression of coronary artery disease: a review. Prog Cardiovasc Dis 1993;35:435-54.
36. Ramsay LE, Yeo WW, Jackson PR. Dietary reduction of serum cholesterol concentration: time to think again. Br Med J 1991;303:953-7.
37. Lindholm LH, Ekbom T, Dash C, et al. The impact of health care advice given in primary care on cardiovascular risk. Br Med J 1995;310:1105-9.
38. Neil HAW, Roe L, Godlee JW, et al. Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. Br Med J 1995;310:569-73.
39. Oliver MF. Statins prevent coronary heart disease. Lancet 1995;346:1378-9.
40. Holme I. Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomized trials: use of meta-analysis. Br Heart J 1993;69;S42-50.
41. Mattison FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985;26:194-202.
42. Stamler J. Assessing diets to improve world health: nutritional research on disease causation in populations. Am J Clin Nutr 1994;59(suppl):146S-56S.
43. Oliver MF. Which changes in diet prevent coronary heart disease? A review of clinical trials of dietary fats and antioxidants. Acta Cardiol 1996;51:467-90.